- 150 eligible subjects with DME will be enrolled and randomized to one of 5 treatment groups, i.e., one of three doses of Luminate intravitreal injection or Avastin intravitreal injection or focal laser photocoagulation. Subjects will be followed monthly for 24 weeks (6 months)